LEUKERAN

This brand name is authorized in Australia, Brazil, Canada, Estonia, Finland, Hong Kong, Ireland, Israel, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United States

Active ingredients

The drug LEUKERAN contains one active pharmaceutical ingredient (API):

1 Chlorambucil UNII 18D0SL7309 - CHLORAMBUCIL

Chlorambucil is an aromatic nitrogen mustard derivative which acts as a bifunctional alkylating agent. In addition to interference with DNA replication, chlorambucil induces cellular apoptosis via the accumulation of cytosolic p53 and subsequent activation of an apoptosis promoter. Read about Chlorambucil

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LEUKERAN Tablets	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01AA02	Chlorambucil	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AA Nitrogen mustard analogues
Discover more medicines within L01AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1163F
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 505617060041717
Country: CA	Health Products and Food Branch	Identifier(s): 00004626
Country: EE	Ravimiamet	Identifier(s): 1007345
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 378501
Country: HK	Department of Health Drug Office	Identifier(s): 03789
Country: IE	Health Products Regulatory Authority	Identifier(s): 31461
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 1112
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1002234, 1069682
Country: MT	Medicines Authority	Identifier(s): MA955/00301
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 50481
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 1694
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 2376
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100194811, 100330450, 100454307
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W58866002
Country: SG	Health Sciences Authority	Identifier(s): 11696P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699874080038
Country: US	FDA, National Drug Code	Identifier(s): 76388-635